The altered expression of long non-coding RNAs: GHET1, BACE1-AS, PANDA, UCA1 associated with non-small cell lung cancer
Researcher Bulletin of Medical Sciences,
Vol. 27 No. 1 (2022),
20 November 2022
,
Page e10
Abstract
Objective: Long non-coding RNAs (lncRNAs) are characterized as non-coding transcripts greater than 200 nucleotides. lncRNAs have extensive molecular connections with proteins and microRNAs, which are important in the regulation of gene expression in physiologic and pathologic states including cancer. About 18% of human LncRNAs were recently found to be associated with tumours. Many studies indicated that aberrant expression of LncRNAs play key roles in the progression and metastasis of NSCLC. In this study we evaluated the expression of long non-coding RNAs: GHET1, BACE1-AS, PANDA, UCA1 in non-small cell lung cancer.
Material & Methods: In this study, RNA was extracted from tumor tissues of NSCLC and paired adjacent normal lung tissues. After cDNA synthesis, the relative expression level of lncRNA GHET1, BACE1-AS, PANDA, and UCA1 genes was studied by TaqMan Real-Time PCR, and the data were analyzed by 2-∆∆CT. The t-test was used to compare the values and P-value < 0.05 was considered statistically significant.
Results: The data of qRT-PCR analysis revealed that the expression level of GHET1 gene in patients with NSCLC is increased (P= 0.0032) and BACE1-AS showed down-regulation (P= 0.0093). There was no significant change in the expression of PANDA and UCA1 genes.
Conclusion: Our study sheds lights on the expression signature of several crucial lncRNAs in human lung cancer. This data not only could be further be utilized for different therapeutic approaches but also reveal the changes in biological processes of human lung tumors.
- BACE1; GHET1;lncRNA; Lung cancer;PANDA
How to Cite
References
2. Nana-Sinkam SP, Croce CM. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Molecular oncology. 2011;5(6):483-91.
3. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223-7.
4. Fang C, Wang L, Gong C, Wu W, Yao C, Zhu S. Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer. Journal of cellular and molecular medicine. 2020;24(6):3282-91.
5. Lv X-B, Lian G-Y, Wang H-R, Song E, Yao H, Wang M-H. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PloS one. 2013;8(5):e63516.
6. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase. Nature medicine. 2008;14(7):723-30.
7. Modarresi F, Faghihi MA, Patel NS, Sahagan BG, Wahlestedt C, Lopez-Toledano MA. Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis. International Journal of Alzheimer’s Disease. 2011;2011.
8. Ding G, Li W, Liu J, Zeng Y, Mao C, Kang Y, et al. LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 2017;94:326-31.
9. Sun W, Yang Y, Xu C, Xie Y, Guo J. Roles of long noncoding RNAs in gastric cancer and their clinical applications. Journal of cancer research and clinical oncology. 2016;142(11):2231-7.
10. Zhou J, Li X, Wu M, Lin C, Guo Y, Tian B. Knockdown of long noncoding RNA GHET1 inhibits cell proliferation and invasion of colorectal cancer. Oncology research. 2016;23(6):303.
11. Wang Y, Zhang M, Xu H, Wang Y, Li Z, Chang Y, et al. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway. Oncotarget. 2017;8(42):72182.
12. Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR‐184 expression. Cancer medicine. 2017;6(12):2897-908.
13. Qian Y, Liu D, Cao S, Tao Y, Wei D, Li W, et al. Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Molecular cancer. 2017;16(1):1-7.
14. LlVAK K, Schmittgen T. Analysis of relative gene expression data using real-time quanti tative PCR and the 2 (-MC (T)) Method. Methods. 2001;25:402-8.
15. Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033-55.
16. Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539(7629):452-5.
17. Vadaie N, Morris KV. Long antisense non-coding RNAs and the epigenetic regulation of gene expression. Biomolecular concepts. 2013;4(4):411-5.
18. Guan Z-B, Cao Y-S, Li Y, Tong W-N, Zhuo A-S. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer. Cancer Biomarkers. 2018;21(3):557-63.
19. Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, et al. Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stability. The FEBS journal. 2014;281(3):802-13.
20. Ling W, Yangchun X, Wei W, Qiang W. Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo. Cancer Biomarkers. 2020(Preprint):1-12.
21. Yaghoobi H, Azizi H, Banitalebi-Dehkordi M, Rezaei FM, Arsang-Jnag S, Taheri M, et al. Beta-secretase 1 (BACE1) is down-regulated in invasive ductal carcinoma of breast. Reports of biochemistry & molecular biology. 2019;8(2):200.
22. Yeganeh Z, Nabi M, Solymani S, Yazdian S, Razavinia A, Khalili A. The role of long-range non-coding RNAs NeST, NTT, BACE1-AS, CCAT2, FOXCUT and HULC as predictor biomarkers in breast cancer. Gene Reports. 2020;20:100687.
23. Decourt B, Sabbagh MN. BACE1 as a potential biomarker for Alzheimer's disease. Journal of Alzheimer's Disease. 2011;24(s2):53-9.
24. Peng C, Hu W, Weng X, Tong R, Cheng S, Ding C, et al. Over expression of long non-coding RNA PANDA promotes hepatocellular carcinoma by inhibiting senescence associated inflammatory factor IL8. Scientific reports. 2017;7(1):1-11.
25. Inamura K. Major tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancer. Cells. 2017;6(2):12.
26. Wang W, Hu W, Wang Y, An Y, Song L, Shang P, et al. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Molecular cancer. 2020;19(1):18.
27. Chen X, Wang Z, Tong F, Dong X, Wu G, Zhang R. lncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer. Molecular Therapy-Nucleic Acids. 2020;19:643-53.
- Abstract Viewed: 75 times